< 回列表
洪志強
- Director, Division of Breast surgery, Department of Surgery, Taichung Veterans General Hospital
Real-World Data on Treatment Efficacy in Patients With Residual HER2-Positive Early Breast Cancer
| 角色 | 講師 |
| 日期時間 | 05/03 11:40 - 11:50 |
| 地點 | 701B |
學歷 / 訓練
2026, Doctoral Program in Translatio nal Medic ine, National Chung Hsing University
2015, Master of medical science, Chung Shan Medical University
2007, M.D., National Defense Medical Center (
專業與研究經歷
2018 - Present, Director, Division of Breast surgery, Department of Surgery, Taichung Veterans General Hospital
2015 - 2017, Attending Surgeon, Division of General Surgery, Department of Surgery, Taichung Veterans General Hospital
2013 - 2014, Attending Surgeon, Division of General Surgery, Department of Surgery, Chia-Yi Branch, Taichung Veterans General Hospital
2007 - 2012, Resident, Department of Surgery, Taichung Veterans General Hospital
重要出版品
- Hung CC, Wang YC, Liu CH, Lin ML, Chen SS, Shih HY, Yang YC, Hsia TC, Su CH, Chang WS, Bau DT, Tsai CW. Impact of Interleukin-12B Genotypes on Breast Cancer Risk. Anticancer Res. 2025 Nov;45(11):4771-4781. doi: 10.21873/anticanres.17826. PMID: 41151880. {IF: 1.7, Q4}
- Wu CJ, Hung CC, Jheng YW, Liu LC, Wang YJ. Comparing Symptom Clusters in Recurrent Breast Cancer Survivors: A Latent Profile Analysis. West J Nurs Res. 2025 Jul;47(7):613-620. doi: 10.1177/01939459251331395. Epub 2025 Apr 12. PMID: 40219950.
- Chan SW, Lin CA, Ouyang YC, Chen GY, Chang CI, Lin CY, Hung CC, Lum CY, Wang KC, Liu MC. Characterizing Breast Tumor Heterogeneity Through IVIM-DWI Parameters and Signal Decay Analysis. Diagnostics (Basel). 2025 Jun 12;15(12):1499. doi: 10.3390/diagnostics15121499. PMID: 40564820; PMCID: PMC12191917.
- Lin YH, Lin CM, Man KM, Hung CC, Hsu HL, Chen Y, Mu HY, Hsiao TH, Huang JH. Real-time and regional analysis of the efficacy of anticancer drugs in a patient-derived intratumoral heterogeneous tumor microenvironment. Lab Chip. 2025 Mar 25;25(7):1728-1743. doi: 10.1039/d4lc00990h. PMID: 40008895.
- Hung CC, Wang YC, Shih HY, Liu CH, He JL, Chen JC, Chang WS, Su CH, Bau DT, Tsai CW. Significant Association of Matrix Metalloproteinase-9 Polymorphisms With Triple Negative Breast Cancer Risk. Cancer Genomics Proteomics. 2025 Mar-Apr;22(2):258-270. doi: 10.21873/cgp.20500. PMID: 39993804; PMCID: PMC11880922. {IF: 2.6, Q2}
- Lin, Y. H., Lin, C. M., Man, K. M., Hung, C. C., Hsu, H. L., Chen, Y., Mu, H. Y., Hsiao, T. H., & Huang, J. H. (2025). Real-time and regional analysis of the efficacy of anticancer drugs in a patient-derived intratumoral heterogeneous tumor microenvironment. Lab on a chip, 10.1039/d4lc00990h. Advance online publication. https://doi.org/10.1039/d4lc00990h